Profile
QNRX NVO VRTX REGN SGEN MRNA
Company Name Quoin Pharmaceuticals, Ltd. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Moderna, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $858.88K $578.19B $107.80B $104.31B $43.15B $42.34B
Employees 0.00K 63.37K 5.40K 13.45K 3.26K 5.60K
CEO Dr. Michael Myers Ph.D. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Stephane Bancel
Ratings
QNRX NVO VRTX REGN SGEN MRNA
Quant Rating Score 3 5 5 5 3 4
Quant Rating Neutral Strong Buy Strong Buy Strong Buy Neutral Buy
Trading
QNRX NVO VRTX REGN SGEN MRNA
Last Close $0.87 $128.05 $417.32 $966.3 $228.74 $110.59
High 52 $9.09 $199.54 $446.08 $993.35 $228.9 $160.53
Low 52 $0.42 $87.78 $313.25 $692.45 $187.64 $69.51
Price vs. 52 Week High -90.43 % -35.83 % -6.45 % -2.72 % -0.07 % -31.11 %
Price vs. 52 Week Low 107.14 % 45.88 % 33.22 % 39.55 % 21.9 % 59.1 %
Total Return
QNRX NVO VRTX REGN SGEN MRNA
1 Month Return -66.67 % 5.36 % -2.26 % -2.16 % 0 % 13.45 %
3 Month Return -83.1 % 23.76 % 1.97 % 9.6 % 0 % 11.94 %
6 Month Return -79.68 % 39.91 % 18.39 % 15.78 % 7.77 % 10.29 %
9 Month Return 65.97 % -18.33 % 18.97 % 38.04 % 17.99 % -10.09 %
YTD Return -82.26 % 23.78 % 2.56 % 10.02 % 0 % 11.2 %
1 Year Return 81.82 % -17.56 % 33.22 % 16.85 % 12.67 % -24.73 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
QNRX NVO VRTX REGN SGEN MRNA
Dividend Yield Percentage (TTM) - 1.21 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) - 1.54 % 10.64 % 5.88 % -3.35 % -3.75 %
Dividend Per Share (TTM) - 1.55 % - - - -
Payout Ratio (TTM) - 37.96 % 2.04 % - - -2.63 %
Growth
QNRX NVO VRTX REGN SGEN MRNA
Asset Growth 54.52 % 30.35 % 25.23 % 13.23 % -1.21 % -28.74 %
Gross Profit Growth 0.46 % 32.32 % 9.25 % 6.49 % 22.93 % -85.12 %
Revenue Growth - 31.26 % 10.17 % 7.76 % 24.65 % -64.94 %
Revenue 3 Year - 90.5 % 60.31 % 56.27 % 91.84 % 2354.12 %
Revenue 5 Year - 124.05 % 221.21 % 97.36 % 215.48 % 1070.62 %
Revenue 10 Year - 65.67 % 600.89 % 509.63 % 494.04 % 6447.35 %
EBIT Growth 56.56 % 37.11 % -12.94 % -14.6 % 10.13 % -145 %
Net Income Growth -8.91 % 50.71 % 8.96 % -8.87 % 9.51 % -156.37 %
Net Income 3 Yeari Growth Per Share 41.01 % 106.78 % 34.96 % 13.92 % -764.83 % -529.35 %
Net Income 5 Yeari Growth Per Share - 133.7 % 71.75 % 63.31 % -276.93 % -160.17 %
Net Income 10 Yeari Growth Per Share - 98.08 % 802.21 % 811.34 % -624.16 % -2046.03 %
Operating Income Growth 56.56 % 37.11 % -12.94 % -14.6 % 10.13 % -145 %
Operating Cash Flow Growth (CFG) -48.26 % 38.06 % -14.35 % -8.39 % 9.07 % -162.6 %
Operating 3 Year CFG 35.22 % 118.27 % 9.93 % 77.63 % -148.34 % -253.42 %
Operating 5 Year CFG - 163.33 % 177.06 % 111.31 % -195.86 % -100.11 %
Operating 10 Year CFG - 150.25 % 5134.08 % 663.48 % -2622.09 % -4698.89 %
EPS Growth 85.8 % 52.28 % 8.33 % -8.54 % 10.81 % -158.04 %
EPS Diluted Growth 85.8 % 52.37 % 8.35 % -9.03 % 10.81 % -161.33 %
Book Value Per Share 46.99 % 29.05 % 25.68 % 14.4 % -9.83 % -21.11 %
Share Holder 3 Year Equity Growth Per Share -82.89 % 75.21 % 104.63 % 138.48 % 33.92 % 439.47 %
Share Holder 5 Year Equity Growth Per Share - 121.75 % 294.38 % 199.46 % 220.81 % 92.24 %
Share Holder 10 Year Equity Growth Per Share - 49.22 % 1019.01 % 1201.51 % 691.19 % 1519.81 %
Dividend Per Share Growth - 26.94 % - - - 59.8 %
Dividend 3 Year Growth Per Share - 64.38 % -100 % - - 3725.19 %
Dividend 5 Year Growth Per Share - 79.91 % -100 % - - -
Dividend 10 Year Growth Per Share - 94.92 % - - - -
Debt Growth -100 % 4.74 % 44.1 % 0.06 % -23.28 % 3.58 %
Free Cash Flow Growth -37.6 % 9.17 % -16.47 % -17.11 % 3.67 % -183.5 %
Updated On 31 Dec 2022 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
QNRX NVO VRTX REGN SGEN MRNA
Gross Profit Margin TTM - 84.6 % 87.21 % 87.87 % 75.4 % 31.49 %
Return on Assets TTM -69.76 % 26.61 % 15.92 % 11.95 % -20.64 % -25.58 %
Return on Equity TTM -102.71 % 90.49 % 22.62 % 16.07 % -28.06 % -29.87 %
Return on Capital Employed TTM -105.93 % 70.82 % 19.82 % 13.65 % -29.5 % -27.51 %
Net Income Per EBT TTM 97.49 % 79.95 % 82.64 % 94.15 % 101.53 % 119.58 %
EBT Per Ebit TTM 95.73 % 102.05 % 115.19 % 103.76 % 93.47 % 92.99 %
EBIT Per Revenue TTM - 44.16 % 38.53 % 30.85 % -34.37 % -61.88 %
Cash Flow To Debt Ratio TTM - 403.27 % 437.57 % 169.97 % -475.96 % -250.84 %
Receivables Turnover TTM - 3.09 6.31 2.31 3.64 6.34
Payables Turnover TTM 0.2 1.4 3.46 2.62 2.52 9.03
Inventory Turnover TTM - 1.12 1.71 0.62 1.07 23.23
Fixed Asset Turnover TTM - 255.34 % 679.28 % 316.35 % 471.71 % 257.71 %
Asset Turnover TTM - 73.85 % 43.42 % 39.65 % 63.3 % 37.18 %
Operating Cash Flow Per Share TTM -8 24.39 13.73 40.37 -2.87 -8.18
Free Cash Flow Per Share TTM -8 15.68 12.72 33.51 -3.73 -10.04
Cash Per Share TTM 1083.34 % 677.09 % 4354.48 % 9530.85 % 657.5 % 2258.27 %
Operating Cash Flow Sales Ratio TTM - 46.89 % 35.84 % 35.02 % -23.48 % -45.52 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 64.29 % 92.69 % 83.01 % 129.82 % 122.67 %
Cash Flow Coverage Ratios TTM - 403.27 % 437.57 % 169.97 % -475.96 % -250.84 %
Price To Free Cash Flows Ratio TTM -0.11 57.11 32.88 27.35 -61.54 -11.07
Price To Operating Cash Flows Ratio TTM -0.11 36.3 30.4 23.93 -79.67 -13.51
Price Cash Flow Ratio TTM -0.11 36.3 30.4 23.93 -79.67 -13.51
Income Statement (TTM)
QNRX NVO VRTX REGN SGEN MRNA
Revenue $0B $232.26B $9.84B $13.12B $1.96B $6.75B
Gross Profit $-0B $196.5B $8.58B $11.3B $1.55B $2.06B
Gross Profit Ratio 0% 84.6% 87.17% 86.16% 79.1% 30.52%
EBITDA $-0.01B $112.94B $3.93B $5.13B $-0.62B $-3.21B
Net Income $-0.01B $83.68B $3.62B $3.95B $-0.61B $-4.71B
EPS Diluted -9.62 18.62 13.89 34.77 -3.3 -12.34
Balance Sheet (MRQ)
QNRX NVO VRTX REGN SGEN MRNA
Long Term Debt $0B $20.53B $0.72B $2.7B $0.04B $1.22B
Total Liabilities $0.01B $207.93B $5.15B $7.11B $0.87B $4.57B
Total Equity $0.01B $106.56B $17.58B $25.97B $2.8B $13.85B
Total Investments $0.01B $17.5B $3.45B $13.51B $1.42B $4.68B
Total Debt $0B $27.01B $0.81B $2.7B $0.04B $1.24B
Total Assets $0.01B $314.49B $22.73B $33.08B $3.67B $18.43B
Cash Flow Statement (TTM)
QNRX NVO VRTX REGN SGEN MRNA
Net Income $-0.01B $83.68B $3.62B $3.95B $-0.61B $-4.71B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $0.75B
Dividends Paid $0B $-31.77B $0B $0B $0B $-0.27B
Operating Cash Flow $-0.01B $108.91B $3.54B $4.59B $-0.45B $-3.12B
Capital Expenditure $0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.71B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.335
ABCL AbCellera Biologics Inc. 4.53
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 7.205
ABIO ARCA biopharma, Inc. 1.76
ABOS Acumen Pharmaceuticals, Inc. 4.05
ABSI Absci Corporation 5.695
ABUS Arbutus Biopharma Corporation 2.59
ABVC ABVC BioPharma, Inc. 1.2961
ABVX Abivax SA American Depositary Shares 14.1
ACAD ACADIA Pharmaceuticals Inc. 18.475
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 2.345
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.2501
ACHV Achieve Life Sciences, Inc. 4.5681
ACIU AC Immune SA 2.99
ACLX Arcellx, Inc. 69.73
ACRV Acrivon Therapeutics, Inc. Common Stock 7.04
ACST Acasti Pharma Inc. 3.41
Unlock